1. Cohen JD, Brinton EA, Ito MK, et al. Understanding statin use in America and gaps in patient education (USAGE): an internet-based survey of 10,138 current and former statin users. J Clin Lipidol 2012;6:208-15 [PubMed]. 
  2. Thompson PD. What to believe and do about statin-associated adverse effects. JAMA 2016;316:1969-70. 
  3. Stroes ES, Thompson PD, Corsini A, et al. Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management. Eur Heart J 2015 [PubMed]. 
  4. Schaffer AL, Buckley NA, Dobbins TA, et al. The crux of the matter: Did the ABC's Catalyst program change statin use in Australia? Med J Aust 2015;202:591-5 [PubMed]. 
  5. Bruckert E, Hayem G, Dejager S, et al. Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study. Cardiovasc Drugs Ther 2005;19:403-14 [PubMed]. 
  6. Rosenson RS, Baker SK, Jacobson TA, et al. An assessment by the Statin Muscle Safety Task Force: 2014 update. J Clin Lipidol 2014;8:S58-71 [PubMed]. 
  7. Catapano AL, Graham I, De Backer G, et al. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart J 2016;37:2999-3058 [PubMed]. 
  8. Thompson PD, Panza G, Zaleski A, et al. Statin-associated side effects. J Am Coll Cardiol 2016;67:2395-410 [PubMed]. 
  9. Ganga HV, Slim HB, Thompson PD. A systematic review of statin-induced muscle problems in clinical trials. Am Heart J 2014;168:6-15 [PubMed]. 
  10. American College of Cardiology. Statin Intolerance App. 2016.[Online] (accessed 1 March 2017).
  11. Zhang H, Plutzky J, Skentzos S, et al. Discontinuation of statins in routine care settings: a cohort study. Ann Intern Med 2013;158:526-34 [PubMed].